 | • レポートコード：GIR-105X13191 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Medical Devices & Consumables |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、パクリタキセル溶出ステントのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。パクリタキセル溶出ステントの種類別市場規模（金属ステント、ポリマーステント、その他）、用途別市場規模（冠状動脈性心臓病、臨床、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・パクリタキセル溶出ステントの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：B.Braun Melsengen AG、Biosensors、Biotronik、Blue Medical、Boston Scientific、DISA Vascular、Essen、Medtronic Vascular、MicroPort Medical、Terumo Medical、Orbusneich ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：金属ステント、ポリマーステント、その他 ・用途別分析2016年-2026年：冠状動脈性心臓病、臨床、その他 ・パクリタキセル溶出ステントの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・パクリタキセル溶出ステントのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・パクリタキセル溶出ステントのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・パクリタキセル溶出ステントの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・パクリタキセル溶出ステントの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Paclitaxel-eluting Stent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Paclitaxel-eluting Stent size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Paclitaxel-eluting Stent market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Paclitaxel-eluting Stent market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Metal Stent
Polymer Stent
Others
Market segment by Application can be divided into
Coronary Heart Disease
Clinical
Others
The key market players for global Paclitaxel-eluting Stent market are listed below:
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
Terumo Medical
Orbusneich
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Paclitaxel-eluting Stent Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Paclitaxel-eluting Stent Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Metal Stent
1.2.3 Polymer Stent
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Paclitaxel-eluting Stent Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.3.4 Others
1.4 Global Paclitaxel-eluting Stent Market Size & Forecast
1.4.1 Global Paclitaxel-eluting Stent Sales in Value (2016-2026))
1.4.2 Global Paclitaxel-eluting Stent Sales in Volume (2016-2026)
1.4.3 Global Paclitaxel-eluting Stent Price by Type (2016-2026) & (USD/Unit)
1.5 Global Paclitaxel-eluting Stent Production Capacity Analysis
1.5.1 Global Paclitaxel-eluting Stent Total Production Capacity (2016-2026)
1.5.2 Global Paclitaxel-eluting Stent Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Paclitaxel-eluting Stent Market Drivers
1.6.2 Paclitaxel-eluting Stent Market Restraints
1.6.3 Paclitaxel-eluting Stent Trends Analysis
2 Manufacturers Profiles
2.1 B.Braun Melsengen AG
2.1.1 B.Braun Melsengen AG Details
2.1.2 B.Braun Melsengen AG Major Business
2.1.3 B.Braun Melsengen AG Paclitaxel-eluting Stent Product and Services
2.1.4 B.Braun Melsengen AG Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Biosensors
2.2.1 Biosensors Details
2.2.2 Biosensors Major Business
2.2.3 Biosensors Paclitaxel-eluting Stent Product and Services
2.2.4 Biosensors Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Biotronik
2.3.1 Biotronik Details
2.3.2 Biotronik Major Business
2.3.3 Biotronik Paclitaxel-eluting Stent Product and Services
2.3.4 Biotronik Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Blue Medical
2.4.1 Blue Medical Details
2.4.2 Blue Medical Major Business
2.4.3 Blue Medical Paclitaxel-eluting Stent Product and Services
2.4.4 Blue Medical Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Boston Scientific
2.5.1 Boston Scientific Details
2.5.2 Boston Scientific Major Business
2.5.3 Boston Scientific Paclitaxel-eluting Stent Product and Services
2.5.4 Boston Scientific Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 DISA Vascular
2.6.1 DISA Vascular Details
2.6.2 DISA Vascular Major Business
2.6.3 DISA Vascular Paclitaxel-eluting Stent Product and Services
2.6.4 DISA Vascular Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Essen
2.7.1 Essen Details
2.7.2 Essen Major Business
2.7.3 Essen Paclitaxel-eluting Stent Product and Services
2.7.4 Essen Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Medtronic Vascular
2.8.1 Medtronic Vascular Details
2.8.2 Medtronic Vascular Major Business
2.8.3 Medtronic Vascular Paclitaxel-eluting Stent Product and Services
2.8.4 Medtronic Vascular Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 MicroPort Medical
2.9.1 MicroPort Medical Details
2.9.2 MicroPort Medical Major Business
2.9.3 MicroPort Medical Paclitaxel-eluting Stent Product and Services
2.9.4 MicroPort Medical Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Terumo Medical
2.10.1 Terumo Medical Details
2.10.2 Terumo Medical Major Business
2.10.3 Terumo Medical Paclitaxel-eluting Stent Product and Services
2.10.4 Terumo Medical Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Orbusneich
2.11.1 Orbusneich Details
2.11.2 Orbusneich Major Business
2.11.3 Orbusneich Paclitaxel-eluting Stent Product and Services
2.11.4 Orbusneich Paclitaxel-eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Paclitaxel-eluting Stent Sales by Manufacturer
3.1 Global Paclitaxel-eluting Stent Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Paclitaxel-eluting Stent Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Paclitaxel-eluting Stent
3.4 Market Concentration Rate
3.4.1 Top 3 Paclitaxel-eluting Stent Manufacturer Market Share
3.4.2 Top 6 Paclitaxel-eluting Stent Manufacturer Market Share
3.5 Global Paclitaxel-eluting Stent Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Paclitaxel-eluting Stent Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Paclitaxel-eluting Stent Market Size by Region
4.1.1 Global Paclitaxel-eluting Stent Sales in Volume by Region (2016-2026)
4.1.2 Global Paclitaxel-eluting Stent Revenue by Region (2016-2026)
4.2 North America Paclitaxel-eluting Stent Revenue (2016-2026)
4.3 Europe Paclitaxel-eluting Stent Revenue (2016-2026)
4.4 Asia-Pacific Paclitaxel-eluting Stent Revenue (2016-2026)
4.5 South America Paclitaxel-eluting Stent Revenue (2016-2026)
4.6 Middle East and Africa Paclitaxel-eluting Stent Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Paclitaxel-eluting Stent Sales in Volume by Type (2016-2026)
5.2 Global Paclitaxel-eluting Stent Revenue by Type (2016-2026)
5.3 Global Paclitaxel-eluting Stent Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Paclitaxel-eluting Stent Sales in Volume by Application (2016-2026)
6.2 Global Paclitaxel-eluting Stent Revenue by Application (2016-2026)
6.3 Global Paclitaxel-eluting Stent Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Paclitaxel-eluting Stent Sales by Type (2016-2026)
7.2 North America Paclitaxel-eluting Stent Sales by Application (2016-2026)
7.3 North America Paclitaxel-eluting Stent Market Size by Country
7.3.1 North America Paclitaxel-eluting Stent Sales in Volume by Country (2016-2026)
7.3.2 North America Paclitaxel-eluting Stent Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Paclitaxel-eluting Stent Sales by Type (2016-2026)
8.2 Europe Paclitaxel-eluting Stent Sales by Application (2016-2026)
8.3 Europe Paclitaxel-eluting Stent Market Size by Country
8.3.1 Europe Paclitaxel-eluting Stent Sales in Volume by Country (2016-2026)
8.3.2 Europe Paclitaxel-eluting Stent Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Paclitaxel-eluting Stent Sales by Type (2016-2026)
9.2 Asia-Pacific Paclitaxel-eluting Stent Sales by Application (2016-2026)
9.3 Asia-Pacific Paclitaxel-eluting Stent Market Size by Region
9.3.1 Asia-Pacific Paclitaxel-eluting Stent Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Paclitaxel-eluting Stent Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Paclitaxel-eluting Stent Sales by Type (2016-2026)
10.2 South America Paclitaxel-eluting Stent Sales by Application (2016-2026)
10.3 South America Paclitaxel-eluting Stent Market Size by Country
10.3.1 South America Paclitaxel-eluting Stent Sales in Volume by Country (2016-2026)
10.3.2 South America Paclitaxel-eluting Stent Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Paclitaxel-eluting Stent Sales by Type (2016-2026)
11.2 Middle East & Africa Paclitaxel-eluting Stent Sales by Application (2016-2026)
11.3 Middle East & Africa Paclitaxel-eluting Stent Market Size by Country
11.3.1 Middle East & Africa Paclitaxel-eluting Stent Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Paclitaxel-eluting Stent Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Paclitaxel-eluting Stent Typical Distributors
12.3 Paclitaxel-eluting Stent Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Paclitaxel-eluting Stent Revenue by Type, (USD Million), 2021-2026
Table 2. Global Paclitaxel-eluting Stent Revenue by Application, (USD Million), 2021-2026
Table 3. B.Braun Melsengen AG Basic Information, Manufacturing Base and Competitors
Table 4. B.Braun Melsengen AG Major Business
Table 5. B.Braun Melsengen AG Paclitaxel-eluting Stent Product and Services
Table 6. B.Braun Melsengen AG Paclitaxel-eluting Stent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Biosensors Basic Information, Manufacturing Base and Competitors
Table 8. Biosensors Major Business
Table 9. Biosensors Paclitaxel-eluting Stent Product and Services
Table 10. Biosensors Paclitaxel-eluting Stent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Biotronik Basic Information, Manufacturing Base and Competitors
Table 12. Biotronik Major Business
Table 13. Biotronik Paclitaxel-eluting Stent Product and Services
Table 14. Biotronik Paclitaxel-eluting Stent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Blue Medical Basic Information, Manufacturing Base and Competitors
Table 16. Blue Medical Major Business
Table 17. Blue Medical Paclitaxel-eluting Stent Product and Services
Table 18. Blue Medical Paclitaxel-eluting Stent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 20. Boston Scientific Major Business
Table 21. Boston Scientific Paclitaxel-eluting Stent Product and Services
Table 22. Boston Scientific Paclitaxel-eluting Stent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. DISA Vascular Basic Information, Manufacturing Base and Competitors
Table 24. DISA Vascular Major Business
Table 25. DISA Vascular Paclitaxel-eluting Stent Product and Services
Table 26. DISA Vascular Paclitaxel-eluting Stent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Essen Basic Information, Manufacturing Base and Competitors
Table 28. Essen Major Business
Table 29. Essen Paclitaxel-eluting Stent Product and Services
Table 30. Essen Paclitaxel-eluting Stent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Medtronic Vascular Basic Information, Manufacturing Base and Competitors
Table 32. Medtronic Vascular Major Business
Table 33. Medtronic Vascular Paclitaxel-eluting Stent Product and Services
Table 34. Medtronic Vascular Paclitaxel-eluting Stent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 36. MicroPort Medical Major Business
Table 37. MicroPort Medical Paclitaxel-eluting Stent Product and Services
Table 38. MicroPort Medical Paclitaxel-eluting Stent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Terumo Medical Basic Information, Manufacturing Base and Competitors
Table 40. Terumo Medical Major Business
Table 41. Terumo Medical Paclitaxel-eluting Stent Product and Services
Table 42. Terumo Medical Paclitaxel-eluting Stent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Orbusneich Basic Information, Manufacturing Base and Competitors
Table 44. Orbusneich Major Business
Table 45. Orbusneich Paclitaxel-eluting Stent Product and Services
Table 46. Orbusneich Paclitaxel-eluting Stent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Paclitaxel-eluting Stent Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Paclitaxel-eluting Stent Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Paclitaxel-eluting Stent, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Paclitaxel-eluting Stent Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Paclitaxel-eluting Stent Production Site of Key Manufacturer
Table 52. Global Paclitaxel-eluting Stent Sales by Region (2016-2021e) & (K Units)
Table 53. Global Paclitaxel-eluting Stent Sales by Region (2021-2026) & (K Units)
Table 54. Global Paclitaxel-eluting Stent Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Paclitaxel-eluting Stent Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Paclitaxel-eluting Stent Sales by Type (2016-2021e) & (K Units)
Table 57. Global Paclitaxel-eluting Stent Sales by Type (2021-2026) & (K Units)
Table 58. Global Paclitaxel-eluting Stent Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Paclitaxel-eluting Stent Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Paclitaxel-eluting Stent Price by Type (2016-2021e) & (USD/Unit)
Table 61. Global Paclitaxel-eluting Stent Price by Type (2021-2026) & (USD/Unit)
Table 62. Global Paclitaxel-eluting Stent Sales by Application (2016-2021e) & (K Units)
Table 63. Global Paclitaxel-eluting Stent Sales by Application (2021-2026) & (K Units)
Table 64. Global Paclitaxel-eluting Stent Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Paclitaxel-eluting Stent Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Paclitaxel-eluting Stent Price by Application (2016-2021e) & (USD/Unit)
Table 67. Global Paclitaxel-eluting Stent Price by Application (2021-2026) & (USD/Unit)
Table 68. North America Paclitaxel-eluting Stent Sales by Country (2016-2021e) & (K Units)
Table 69. North America Paclitaxel-eluting Stent Sales by Country (2021-2026) & (K Units)
Table 70. North America Paclitaxel-eluting Stent Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Paclitaxel-eluting Stent Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Paclitaxel-eluting Stent Sales by Type (2016-2021e) & (K Units)
Table 73. North America Paclitaxel-eluting Stent Sales by Type (2021-2026) & (K Units)
Table 74. North America Paclitaxel-eluting Stent Sales by Application (2016-2021e) & (K Units)
Table 75. North America Paclitaxel-eluting Stent Sales by Application (2021-2026) & (K Units)
Table 76. Europe Paclitaxel-eluting Stent Sales by Country (2016-2021e) & (K Units)
Table 77. Europe Paclitaxel-eluting Stent Sales by Country (2021-2026) & (K Units)
Table 78. Europe Paclitaxel-eluting Stent Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Paclitaxel-eluting Stent Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Paclitaxel-eluting Stent Sales by Type (2016-2021e) & (K Units)
Table 81. Europe Paclitaxel-eluting Stent Sales by Type (2021-2026) & (K Units)
Table 82. Europe Paclitaxel-eluting Stent Sales by Application (2016-2021e) & (K Units)
Table 83. Europe Paclitaxel-eluting Stent Sales by Application (2021-2026) & (K Units)
Table 84. Asia-Pacific Paclitaxel-eluting Stent Sales by Region (2016-2021e) & (K Units)
Table 85. Asia-Pacific Paclitaxel-eluting Stent Sales by Region (2021-2026) & (K Units)
Table 86. Asia-Pacific Paclitaxel-eluting Stent Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Paclitaxel-eluting Stent Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Paclitaxel-eluting Stent Sales by Type (2016-2021e) & (K Units)
Table 89. Asia-Pacific Paclitaxel-eluting Stent Sales by Type (2021-2026) & (K Units)
Table 90. Asia-Pacific Paclitaxel-eluting Stent Sales by Application (2016-2021e) & (K Units)
Table 91. Asia-Pacific Paclitaxel-eluting Stent Sales by Application (2021-2026) & (K Units)
Table 92. South America Paclitaxel-eluting Stent Sales by Country (2016-2021e) & (K Units)
Table 93. South America Paclitaxel-eluting Stent Sales by Country (2021-2026) & (K Units)
Table 94. South America Paclitaxel-eluting Stent Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Paclitaxel-eluting Stent Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Paclitaxel-eluting Stent Sales by Type (2016-2021e) & (K Units)
Table 97. South America Paclitaxel-eluting Stent Sales by Type (2021-2026) & (K Units)
Table 98. South America Paclitaxel-eluting Stent Sales by Application (2016-2021e) & (K Units)
Table 99. South America Paclitaxel-eluting Stent Sales by Application (2021-2026) & (K Units)
Table 100. Middle East & Africa Paclitaxel-eluting Stent Sales by Country (2016-2021e) & (K Units)
Table 101. Middle East & Africa Paclitaxel-eluting Stent Sales by Country (2021-2026) & (K Units)
Table 102. Middle East & Africa Paclitaxel-eluting Stent Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Paclitaxel-eluting Stent Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Paclitaxel-eluting Stent Sales by Type (2016-2021e) & (K Units)
Table 105. Middle East & Africa Paclitaxel-eluting Stent Sales by Type (2021-2026) & (K Units)
Table 106. Middle East & Africa Paclitaxel-eluting Stent Sales by Application (2016-2021e) & (K Units)
Table 107. Middle East & Africa Paclitaxel-eluting Stent Sales by Application (2021-2026) & (K Units)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Paclitaxel-eluting Stent Typical Distributors
Table 111. Paclitaxel-eluting Stent Typical Customers
List of Figures
Figure 1. Paclitaxel-eluting Stent Picture
Figure 2. Global Paclitaxel-eluting Stent Sales Market Share by Type in 2020
Figure 3. Metal Stent
Figure 4. Polymer Stent
Figure 5. Others
Figure 6. Global Paclitaxel-eluting Stent Sales Market Share by Application in 2020
Figure 7. Coronary Heart Disease
Figure 8. Clinical
Figure 9. Others
Figure 10. Global Paclitaxel-eluting Stent Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Paclitaxel-eluting Stent Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Paclitaxel-eluting Stent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Paclitaxel-eluting Stent Sales (2016-2026) & (K Units)
Figure 32. Global Paclitaxel-eluting Stent Production Capacity (2016-2026) & (K Units)
Figure 33. Global Paclitaxel-eluting Stent Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Paclitaxel-eluting Stent Market Drivers
Figure 35. Paclitaxel-eluting Stent Market Restraints
Figure 36. Paclitaxel-eluting Stent Market Trends
Figure 37. Global Paclitaxel-eluting Stent Sales Market Share by Manufacturer in 2020
Figure 38. Global Paclitaxel-eluting Stent Revenue Market Share by Manufacturer in 2020
Figure 39. Paclitaxel-eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Paclitaxel-eluting Stent Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Paclitaxel-eluting Stent Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Paclitaxel-eluting Stent Sales Market Share by Region (2016-2026)
Figure 43. Global Paclitaxel-eluting Stent Revenue Market Share by Region (2016-2026)
Figure 44. North America Paclitaxel-eluting Stent Revenue (2016-2026) & (USD Million)
Figure 45. Europe Paclitaxel-eluting Stent Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Paclitaxel-eluting Stent Revenue (2016-2026) & (USD Million)
Figure 47. South America Paclitaxel-eluting Stent Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Paclitaxel-eluting Stent Revenue (2016-2026) & (USD Million)
Figure 49. Global Paclitaxel-eluting Stent Sales Market Share by Type (2016-2026)
Figure 50. Global Paclitaxel-eluting Stent Revenue Market Share by Type (2016-2026)
Figure 51. Global Paclitaxel-eluting Stent Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Paclitaxel-eluting Stent Sales Market Share by Application (2016-2026)
Figure 53. Global Paclitaxel-eluting Stent Revenue Market Share by Application (2016-2026)
Figure 54. Global Paclitaxel-eluting Stent Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Paclitaxel-eluting Stent Sales Market Share by Country (2016-2026)
Figure 56. North America Paclitaxel-eluting Stent Revenue Market Share by Country (2016-2026)
Figure 57. North America Paclitaxel-eluting Stent Sales Market Share by Type (2016-2026)
Figure 58. North America Paclitaxel-eluting Stent Sales Market Share by Application (2016-2026)
Figure 59. Europe Paclitaxel-eluting Stent Sales Market Share by Country (2016-2026)
Figure 60. Europe Paclitaxel-eluting Stent Revenue Market Share by Country (2016-2026)
Figure 61. Europe Paclitaxel-eluting Stent Sales Market Share by Type (2016-2026)
Figure 62. Europe Paclitaxel-eluting Stent Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Paclitaxel-eluting Stent Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Paclitaxel-eluting Stent Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Paclitaxel-eluting Stent Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Paclitaxel-eluting Stent Sales Market Share by Application (2016-2026)
Figure 67. South America Paclitaxel-eluting Stent Sales Market Share by Country (2016-2026)
Figure 68. South America Paclitaxel-eluting Stent Revenue Market Share by Country (2016-2026)
Figure 69. South America Paclitaxel-eluting Stent Sales Market Share by Type (2016-2026)
Figure 70. South America Paclitaxel-eluting Stent Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Paclitaxel-eluting Stent Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Paclitaxel-eluting Stent Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Paclitaxel-eluting Stent Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Paclitaxel-eluting Stent Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
パクリタキセル溶出ステントの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Paclitaxel-eluting stent is used to prevent cell proliferation and avoid fibrosis that could block the stented artery with the clots in a process called restenosis. The stents are scaffolds that can be placed inside diseased or narrowed coronary arteries to release a drug (at a slow speed) to inhibi…- 薬物溶出ステントの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Drug-eluting stents, also known as medicated coronary stents, are used to inhibit artery blockages that may occur in patients after an angioplasty surgery. A drug-eluting stent is a tiny, expandable metal mesh tube, which is covered with a pharmacologic agent (drug). Drug-eluting stents are used to …
- 冠動脈ステントの世界市場2018-2025 This study focuses on the production side and consumption side of Coronary Stent, presents the global Coronary Stent market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.In terms of production side, this report researches the Cor…
- 世界の心臓血管ステント市場 2021：企業別、地域別、種類・用途別 The Cardiovascular Stent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界の血管自己拡張型ステントシステム市場 2021：企業別、地域別、種類・用途別 The Vascular Self-Expanding Stent System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …